Venus Remedies Limited (NSE:VENUSREM) Stock Catapults 26% Though Its Price And Business Still Lag The Market
The Venus Remedies Limited (NSE:VENUSREM) share price has done very well over the last month, posting an excellent gain of 26%. The last 30 days bring the annual gain to a very sharp 35%.
Although its price has surged higher, given about half the companies in India have price-to-earnings ratios (or “P/E’s”) above 28x, you may still consider Venus Remedies as an attractive investment with its 15.4x P/E ratio. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the reduced P/E.
Earnings have risen firmly for Venus Remedies recently, which is pleasing to see. One possibility…
